Shukra Pharmaceuticals Q4 Results
- BSE: 524632
- NSE: SHUKRAPHAR
- ISIN: INE551C01044
- Sector: Biotechnology & Drugs
BSE
54.15
1.08 (2.04%)
1.08 (2.04%)Volume6.19 L
Updated: Tue 8 Sep, 2026 | 15:51:29
NSE
54.111.04 (1.96%)
1.04 (1.96%)Volume5.98 M
Updated: Tue 8 Sep, 2026 | 15:06:06
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Shukra Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 6.63 | 12.84 | -48.34% |
| Depreciation/ Amortization | 1.01 | 0.84 | 20.13% |
| Operating Income | -0.31 | 26.30 | 0.00% |
| Net Income | -1.72 | 20.36 | 0.00% |
| Other Operating Expenses Total | -0.69 | 2.22 | 0.00% |
| Net Income Before Taxes | 0.38 | 26.83 | -98.58% |
| Total Revenue | 6.32 | 39.13 | -83.84% |
| Selling/ General/ Admin Expenses Total | 0.37 | 2.65 | -85.95% |
| Diluted Normalized EPS | -0.04 | 0.47 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.